ICICI Securities has reaffirmed its BUY rating on Lupin Ltd, setting a target price of Rs 2,275, reflecting a 15% upside from the current market price of Rs 1,975.

Torrent Pharmaceuticals Ltd.

Motilal Oswal Financial Services has reiterated its BUY recommendation for Sun Pharma, assigning a 12-month target price of Rs 1,960, with the stock currently trading at Rs 1,690.

India’s biotechnology industry, one of the fastest-expanding sectors globally, is blazing new trails across healthcare, pharmaceuticals, and sustainability.

Motilal Oswal Financial Services has reiterated its BUY call on Laurus Labs, highlighting a robust earnings trajectory and strategic capital deployment in CDMO and generics segments.

Costco’s decision to introduce discounted pricing on Ozempic and Wegovy marks a pivotal moment in both the U.S.